2Shepherd FA, Rodrigues J, Ciuleanu T, et al. Erlotinib in previously treated non-smell cell lung cancer[J]. N Engl J Med,2005, 353(2) : 123-132.
3Morse L,Calarese P. EGFR-targeted therapy and related skin toxicity[J]. Semin Oncol Nurs,2006,22(3):152 -162.
4Gatzemeier U, Pluzanska A, Szczesna A, et al. Phase Ⅲ study Oferlotinib in combination with cisplatin and gemcitabine in advacced non smell-cell lung cancer:the tarceva lung cancer investigation trial[J]. J Clin Oncol, 2007,25(12): 1545-1552.
5U.Gatzemeier,A·Ardizzoni,K·Horwood,et al.Erlotinib in non-small cell lung cancer (NSCLC):Interim safety analysis of the TRUST study[J].ASCO Meeting Abstracts,2007,25(18S):7645.
